Source: Markets Insider

Aristea: Aristea Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, Sept. 20, 2021 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing ...

Read full article »
Aristea's Competitors | Aristea's News | Aristea's Financials
Stay up-to-date with the latest news on Aristea
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
James Mackay's photo - President & CEO of Aristea

President & CEO

James Mackay

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Aristea